Health Condition 1: A249- Melioidosis, unspecified
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Indian Council of Medical Research
Eligibility
Inclusion criteria
Inclusion criteria: 1. Suspected melioidosis and tuberculosis cases for KAP study. 2. Confirmed melioidosis and tuberculosis cases for sample collection. 3. Glander positive serum samples.
Exclusion criteria
Exclusion criteria: NIL
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To achieve the mentioned sample size. 2. Create a database on the targeted zoonotic diseases, detection, treatment, better prevention and patient management. 3. The outcome from KAP study will be used to develop recommendations at the grass root level to mitigate the burden of zoonotic disease transmission.Timepoint: Outcome 1: 24 weeks. Outcome 2: 48 weeks. Outcome 3: 24 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Metagenomics data will detect known, emerging & unknown or rare zoonotic pathogens of human & veterinary importance. 2. The outcome of this study will build a network within different countries connecting human & animal researchers.Timepoint: Outcome 1: 96 weeks. Outcome 2: 120 weeks. | — |
Countries
India
Contacts
Public ContactDr Chiranjay Mukhopadhyay
Kasturba Medical College, Manipal
Outcome results
None listed